CNS shares slide as profit-taking offsets upgraded FY May 2026 profit and dividend forecasts

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Mon Apr 13, 2026 1:35 pm JST Catalyst

CNS Co.,Ltd. <4076> shares retreated on Monday as a "sell-on-news" reaction overshadowed an upward revision to the company's full-year earnings and dividend forecasts. Following the close of trading on Friday, April 10, CNS raised its consolidated operating profit target for the fiscal year ending May 2026 to 710 million yen (up 27.9% YoY) from 658 million yen, and its net profit forecast to 532 million yen (up 24.5% YoY) from 483 million yen. The year-end dividend forecast was also hiked to 55 yen per share from 50 yen. Despite these upgrades, investors locked in gains on perceptions that the positive catalysts had already been fully priced in.

While CNS maintained its full-year revenue forecast at 8,253 million yen (up 17.8% YoY), citing progress according to plan, profit margins improved significantly. This was driven by a rise in high-margin projects within the Technology Solutions segment. Furthermore, the company reported that selling, general, and administrative (SG&A) expenses came in lower than anticipated, even as it continued to prioritize growth investments.

Alongside the revised full-year outlook, CNS released its third-quarter cumulative results for the period from June 2025 to February 2026. The company reported revenue of 5,717 million yen (up 10.2% YoY), operating profit of 546 million yen (up 29.8% YoY), and net profit of 415 million yen (up 38.6% YoY).

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.